On the decision rules of cost-effective treatment for patients with diabetic foot syndrome

被引:6
|
作者
Goulionis, John E. [1 ]
Vozikis, Athanassios [2 ]
Benos, V. K. [1 ]
Nikolakis, D. [1 ]
机构
[1] Univ Piraeus, Dept Stat & Insurance Sci, 80 Karaoli & Dimitriou St, Piraeus 18534, Greece
[2] Univ Piraeus, Dept Econ Sci, Piraeus, Greece
来源
CLINICOECONOMICS AND OUTCOMES RESEARCH | 2010年 / 2卷
关键词
partially observable Markov decision model; diabetic foot syndrome; cost-effectiveness method;
D O I
10.2147/CEOR.S11981
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To. assess the cost-effectiveness of two treatments (medical treatment and amputation) in patients with diabetic foot syndrome, one of the most disabling diabetic complications. Diabetes mellitus is a massive health care problem worldwide with a current prevalence of 150 millions diabetic cases, estimated to increase to 300 million cases in 2025. Methods: Integrating medical knowledge and advances into the clinical setting is often difficult due to the complexity of the algorithms and protocols. Clinical decision support systems assist the clinician in applying new information to patient care through the analysis of patient-specific clinical variables. We require strategic decision support to analyze the cost-effectiveness of these programs compared to the status quo. We provide a simple partially observable Markov model to investigate that issue, and we propose an heuristic algorithm to find the best policy of intervention. Results: This study assesses the potential cost-effectiveness of two alternative treatment interventions in patients with diabetic foot syndrome. The implementation of the heuristic algorithm solution will assist doctors in clinical decision making, and health care organizations in evaluating medication choices for effective treatment. Finally, our study reveals that treatment programs are highly cost-effective for patients at high risk of diabetic foot ulcers and lower extremity amputations.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 50 条
  • [41] Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects
    Matteo Monami
    Alessia Scatena
    Cesare Miranda
    Luca Monge
    Alessandro De Cassai
    Antonio Volpe
    Rodolfo Tramonta
    Gerardo Medea
    Corrado Bordieri
    Marco Falcone
    Laura Stefanon
    Andrea Bernetti
    Cristina Cappella
    Mauro Gargiulo
    Valentina Lorenzoni
    Germano Scevola
    Eugenio Stabile
    Benedetta Ragghianti
    Giovanni Antonio Silverii
    Roberto da Ros
    Marco Meloni
    Laura Giurato
    Giuseppe Murdolo
    Eleonora Bianchini
    Francesco Gaggia
    Carlotta Gauna
    Francesco Romeo
    Matteo Apicella
    Michele Mantuano
    Luigi Uccioli
    Cristiana Vermigli
    Acta Diabetologica, 2023, 60 : 1449 - 1469
  • [42] Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects
    Monami, Matteo
    Scatena, Alessia
    Miranda, Cesare
    Monge, Luca
    De Cassai, Alessandro
    Volpe, Antonio
    Tramonta, Rodolfo
    Medea, Gerardo
    Bordieri, Corrado
    Falcone, Marco
    Stefanon, Laura
    Bernetti, Andrea
    Cappella, Cristina
    Gargiulo, Mauro
    Lorenzoni, Valentina
    Scevola, Germano
    Stabile, Eugenio
    Ragghianti, Benedetta
    Silverii, Giovanni Antonio
    da Ros, Roberto
    Meloni, Marco
    Giurato, Laura
    Murdolo, Giuseppe
    Bianchini, Eleonora
    Gaggia, Francesco
    Gauna, Carlotta
    Romeo, Francesco
    Apicella, Matteo
    Mantuano, Michele
    Uccioli, Luigi
    Vermigli, Cristiana
    ACTA DIABETOLOGICA, 2023, 60 (11) : 1449 - 1469
  • [43] Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome
    Malyar, Nasser M.
    Freisinger, Eva
    Meyborg, Matthias
    Lueders, Florian
    Gebauer, Katrin
    Reinecke, Holger
    Lawall, Holger
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (06) : 1117 - 1122
  • [44] EXPERIENCE IN USING THE REGULATORY PEPTIDE IMUNOFAN IN TYPE 2 DIABETES PATIENTS WITH DIABETIC FOOT SYNDROME
    Tutelyan, A. V.
    Yokubovskaya, I. A.
    Skrypnik, N. V.
    Lebedev, V. V.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (12) : 16 - 19
  • [45] Standardized Communication Using FHIR and SNOMED CT in Treatment of Diabetic Foot Syndrome Within the Project iFoot
    Ludmann, Dominik
    Pantazoglou, Elisabeth
    Otten, Hubert
    DIGITAL PERSONALIZED HEALTH AND MEDICINE, 2020, 270 : 1395 - 1396
  • [46] The use of dressing materials based on the lipid-colloid technology for the local treatment of diabetic foot syndrome
    Khramilin, V. N.
    DIABETES MELLITUS, 2010, 13 (03): : 129 - 132
  • [47] Immediate And Long-Term Outcomes Of The Treatment Of Patients With Purulent-Necrotic Complications Of The Diabetic Foot Syndrome With The Use Of Programmable Sanation Technologies
    Glukhov, A. A.
    Sergeev, V. A.
    Semenova, G. A.
    Mokhova, O. S.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (04): : 236 - 245
  • [48] Mini-invasive revascularization operations in the complex treatment of neuroischemic and ischemic forms of diabetic foot syndrome
    Zhakiyev, Bazylbek
    Jakanov, Murat
    Zhanabaev, Bernat
    Koyshibaev, Anuar
    Mukanov, Samat
    Aitbayeva, Aliya
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 (04): : 817 - 825
  • [49] The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome - Pilot study in elderly patients
    Koblik, T
    Sieradzki, J
    Sendur, R
    Biernat, J
    Czarnobilski, K
    Gryz, E
    Pawlik, W
    Szczudlik, A
    Gaddi, A
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (02) : 69 - 74
  • [50] Impact of various wound dressings on wound bed neoangiogenesis in patients with different forms of diabetic foot syndrome
    Zaitseva, E. L.
    Tokmakova, A. Yu.
    Doronina, L. P.
    Voronkova, I. A.
    Galstyan, G. R.
    Shestakova, M. V.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (10) : 12 - 16